Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-3.81
↓ 22% vs avg
Percentile
P43
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-3.13
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -3.81 | -17.1% |
| 2024 | -3.25 | -213.9% |
| 2023 | -1.04 | +13.4% |
| 2022 | -1.20 | +85.0% |
| 2021 | -7.95 | +39.0% |
| 2020 | -13.03 | -19642.0% |
| 2019 | 0.07 | -74.1% |
| 2018 | 0.26 | +252.4% |
| 2017 | -0.17 | +85.2% |
| 2016 | -1.14 | - |